This week worries around the yellow fever outbreak in Brazil and its epidemic potential were highlighted, while discussions around how best to control the emerging Ebola outbreak in DRC continued. The New York Times also examined the challenges of controlling outbreaks, but through the lens of the successful campaign to eradicate smallpox.
India received ongoing attention for the introduction of pneumococcal vaccine, and the lives it will save through preventing a key cause of pneumonia.
Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance, explored ways in which the private sector supports immunisation through innovation, and also spoke to Johns Hopkins University about how vaccination can make further progress around the world. Researchers at Results for Development considered how countries will support high levels of vaccine coverage once they have transitioned away from Gavi funding, making the case for careful planning and the use of the immunisation financing tool they developed.
The World Health Organization reported a new agreement between big funders of medical research to report the outcomes of all clinical trials, which could impact vaccination studies in the future.